596 related articles for article (PubMed ID: 21091442)
1. Sphingosine kinase and sphingosine 1-phosphate in asthma.
Lai WQ; Wong WS; Leung BP
Biosci Rep; 2011 Apr; 31(2):145-50. PubMed ID: 21091442
[TBL] [Abstract][Full Text] [Related]
2. Sphingosine kinase signalling in immune cells.
Kee TH; Vit P; Melendez AJ
Clin Exp Pharmacol Physiol; 2005 Mar; 32(3):153-61. PubMed ID: 15743396
[TBL] [Abstract][Full Text] [Related]
3. The role of sphingolipids in respiratory disease.
Yang Y; Uhlig S
Ther Adv Respir Dis; 2011 Oct; 5(5):325-44. PubMed ID: 21900155
[TBL] [Abstract][Full Text] [Related]
4. New players on the center stage: sphingosine 1-phosphate and its receptors as drug targets.
Huwiler A; Pfeilschifter J
Biochem Pharmacol; 2008 May; 75(10):1893-900. PubMed ID: 18321471
[TBL] [Abstract][Full Text] [Related]
5. Control of metabolism and signaling of simple bioactive sphingolipids: Implications in disease.
Gangoiti P; Camacho L; Arana L; Ouro A; Granado MH; Brizuela L; Casas J; Fabriás G; Abad JL; Delgado A; Gómez-Muñoz A
Prog Lipid Res; 2010 Oct; 49(4):316-34. PubMed ID: 20193711
[TBL] [Abstract][Full Text] [Related]
6. Sphingosine kinase/sphingosine 1-phosphate signalling in central nervous system.
Okada T; Kajimoto T; Jahangeer S; Nakamura S
Cell Signal; 2009 Jan; 21(1):7-13. PubMed ID: 18694820
[TBL] [Abstract][Full Text] [Related]
7. Regulation of macrophage function by sphingosine-1-phosphate.
Weigert A; Weis N; Brüne B
Immunobiology; 2009; 214(9-10):748-60. PubMed ID: 19625101
[TBL] [Abstract][Full Text] [Related]
8. Targeting the sphingosine kinase/sphingosine 1-phosphate pathway to treat chronic inflammatory kidney diseases.
Schwalm S; Pfeilschifter J; Huwiler A
Basic Clin Pharmacol Toxicol; 2014 Jan; 114(1):44-9. PubMed ID: 23789924
[TBL] [Abstract][Full Text] [Related]
9. Sphingosine-1-phosphate modulates vascular permeability and cell recruitment in acute inflammation in vivo.
Roviezzo F; Brancaleone V; De Gruttola L; Vellecco V; Bucci M; D'Agostino B; Cooper D; Sorrentino R; Perretti M; Cirino G
J Pharmacol Exp Ther; 2011 Jun; 337(3):830-7. PubMed ID: 21421740
[TBL] [Abstract][Full Text] [Related]
10. Pulmonary and vascular pharmacology of sphingosine 1-phosphate.
Brinkmann V; Baumruker T
Curr Opin Pharmacol; 2006 Jun; 6(3):244-50. PubMed ID: 16563863
[TBL] [Abstract][Full Text] [Related]
11. Activation of the SPHK/S1P signalling pathway is coupled to muscarinic receptor-dependent regulation of peripheral airways.
Pfaff M; Powaga N; Akinci S; Schütz W; Banno Y; Wiegand S; Kummer W; Wess J; Haberberger RV
Respir Res; 2005 May; 6(1):48. PubMed ID: 15927078
[TBL] [Abstract][Full Text] [Related]
12. Sphingosine 1-phosphate signalling in cancer.
Pyne NJ; Tonelli F; Lim KG; Long JS; Edwards J; Pyne S
Biochem Soc Trans; 2012 Feb; 40(1):94-100. PubMed ID: 22260672
[TBL] [Abstract][Full Text] [Related]
13. Sphingosine-1-phosphate is released by cerebellar astrocytes in response to bFGF and induces astrocyte proliferation through Gi-protein-coupled receptors.
Bassi R; Anelli V; Giussani P; Tettamanti G; Viani P; Riboni L
Glia; 2006 Apr; 53(6):621-30. PubMed ID: 16470810
[TBL] [Abstract][Full Text] [Related]
14. Hepatopoietin Cn reduces ethanol-induced hepatoxicity via sphingosine kinase 1 and sphingosine 1-phosphate receptors.
Liu Y; Saiyan S; Men TY; Gao HY; Wen C; Liu Y; Zhou X; Wu CT; Wang LS; Cui CP
J Pathol; 2013 Aug; 230(4):365-76. PubMed ID: 23839903
[TBL] [Abstract][Full Text] [Related]
15. Targeting the conversion of ceramide to sphingosine 1-phosphate as a novel strategy for cancer therapy.
Huwiler A; Zangemeister-Wittke U
Crit Rev Oncol Hematol; 2007 Aug; 63(2):150-9. PubMed ID: 17560117
[TBL] [Abstract][Full Text] [Related]
16. Dissecting the role of the S1P/S1PR axis in health and disease.
Aarthi JJ; Darendeliler MA; Pushparaj PN
J Dent Res; 2011 Jul; 90(7):841-54. PubMed ID: 21248363
[TBL] [Abstract][Full Text] [Related]
17. The control of the balance between ceramide and sphingosine-1-phosphate by sphingosine kinase: oxidative stress and the seesaw of cell survival and death.
Van Brocklyn JR; Williams JB
Comp Biochem Physiol B Biochem Mol Biol; 2012 Sep; 163(1):26-36. PubMed ID: 22613819
[TBL] [Abstract][Full Text] [Related]
18. Sphingosine kinase/sphingosine 1-phosphate signaling in cancer therapeutics and drug resistance.
Selvam SP; Ogretmen B
Handb Exp Pharmacol; 2013; (216):3-27. PubMed ID: 23563649
[TBL] [Abstract][Full Text] [Related]
19. Hypoxia enhances sphingosine kinase 2 activity and provokes sphingosine-1-phosphate-mediated chemoresistance in A549 lung cancer cells.
Schnitzer SE; Weigert A; Zhou J; Brüne B
Mol Cancer Res; 2009 Mar; 7(3):393-401. PubMed ID: 19240180
[TBL] [Abstract][Full Text] [Related]
20. Sphingosine-1-phosphate signaling in the cardiovascular system.
Peters SL; Alewijnse AE
Curr Opin Pharmacol; 2007 Apr; 7(2):186-92. PubMed ID: 17280869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
